The efficacy of gonadotropin-releasing hormone agonist treatment before hysteroscopic myomectomy for large-sized submucosal leiomyoma

To evaluate the efficacy and safety of a gonadotropin-releasing hormone (GnRH) agonist for treating large-sized submucosal leiomyoma before hysteroscopic myomectomy. The data were retrospectively collected from patients who underwent a hysteroscopic myomectomy for a submucosal leiomyoma >3.5 cm i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mia, Song, Min Soon, Kang, Byung Hun, Song, Soo Youn, Lee, Geon Woo, Jung, Ye Won, Shin, Won Kyo, Ko, Young Bok, Lee, Ki Hwan, Yoo, Heon Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351844/
https://www.ncbi.nlm.nih.gov/pubmed/35945797
http://dx.doi.org/10.1097/MD.0000000000029726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351844/
https://www.ncbi.nlm.nih.gov/pubmed/35945797
http://dx.doi.org/10.1097/MD.0000000000029726

Ejemplares similares